Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Dec 20, 2023
Date Accepted: Mar 6, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Supporting the Supporters: Demographics and Trends of a Substance Use Helpline for Concerned Significant Others
ABSTRACT
Background:
Concerned significant others (CSOs) play a significant role in supporting individuals with substance use disorders (SUDs). There are a lack of tailored support services for these CSOs, despite their substantial contributions to the well-being and recovery of their loved ones (LOs). The emergence of helplines as a potential avenue for CSO support is outlined, culminating in the focus on the Partnership to End Addiction's Helpline service, an innovative public health intervention aimed at aiding CSOs concerned about their LO's substance use.
Objective:
The article analyzes the demographic trends and utilization patterns of the Partnership's Helpline service, highlighting the critical role of such services, and advocating for expanded, tailored support models.
Methods:
The study draws data from eight data platforms spanning April 2011 to December 2021, encompassing 24,096 client records. Detailed descriptions of data sources and cleaning procedures are available in the Supplement. Surveys were either completed by Helpline Specialists during synchronous telephone calls, amalgamating CSO-provided information and specialist insights, or self-reported by CSOs before Helpline engagement. Collected information encompasses demographics, interaction language, substance of concern, CSO-LO relationship, and the LO's 'use state,' defining their location on the continuum of substance use and associated consequences.
Results:
CCSOs primarily comprised women (76.1%) seeking support for their children (68.9%). LOs were mostly male (62.7%), aged 18-25 (33%), identifying as heterosexual/straight (90.0%), with primary substance concerns being cannabis (40.9%), opioids (19%), and stimulants (12.1%). CSOs primarily sought aid for LOs struggling with substances who were not in treatment (62.9%). In terms of language, the majority of CSOs were looking for support in English (82.2%), while the rest (17.8%) preferred to communicate in Spanish. Spanish-speaking CSOs were significantly more likely to call about cannabis (53.7% vs. 38.6%): and stimulants (16.9% vs. 11.3%) than English-speaking CSOs (p < .001). On the other hand, English-speaking CSOs were more likely to be concerned about opioids than Spanish-speaking CSOs (21.3% vs. 5.2%). (p < .001).
Conclusions:
The study illuminates the Helpline's pioneering role in aiding concerned significant others grappling with a loved one’s substance use. It highlights helplines as crucial resources for CSOs, revealing key demographic, substance-related, and use-state trends. The dominant presence of women among users aligns with mental health helpline patterns, reflecting traditional caregiving roles. While parents form a significant percentage of those reaching out, support is also sought by siblings, friends, and other family members, emphasizing the need for assistance for other members of an LO’s social network. Spanish-speaking individuals' significant outreach underscores the necessity for bilingual support services due to language and cultural barriers. Substance concerns revolve around cannabis, opioids, and stimulants, influenced by age and language preferences. The Helpline serves as an essential intermediary for CSOs, filling a gap between acute crisis intervention services and formalized health care and treatment services. Future directions involve understanding CSO concerns, user dynamics, outcome assessments, intervention models, and integration into broader care frameworks. Overall, the study highlights this helpline's crucial role in aiding CSOs with tailored, accessible support services. Clinical Trial: N/A
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.